HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMBI

This article was originally published in The Tan Sheet

Executive Summary

Supplement marketer plans a fall launch on the QVC network of Sweet Support dietary supplement bars for people "concerned about maintaining healthy glucose levels." The bars will be sold under a "marketing and brand-building strategic alliance" that gives QVC performance-based warrants to purchase AMBI common stock. Purchase, N.Y.-based AMBI introduced Sweet Support, an addition to the Lite Bites line of nutrition bars, shakes and chewies, at the American Association of Diabetes Educators annual meeting in Orlando Aug. 18-22. In June, the company extended the Lite Bites line with Arginine Silicate Bars for cholesterol benefits (1"The Tan Sheet" June 14, p. 18). Lite Bites have been sold on QVC for three years. AMBI plans to use QVC as a marketing channel for the firm's CardiaNutrition line of cardiovascular health supplement capsules and bars currently under development

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel